Richard Falzone

Richard is the Vice President, Clinical Operations at Verve Therapeutics. He has over 20 years of experience in Clinical Operations, having worked in roles of increasing responsibly and across multiple therapeutic areas at Transkaryotic Therapies, Immunogen, Altus, and Alnylam Pharmaceuticals. Rick received a B.S. in Microbiology from the University of New Hampshire and a Masters Degree in Public Health from Tufts University.